Kaiser Health News

New Alzheimer’s drug raises hopes — along with questions

Last year

R&D

CDC to reduce funding for states’ child vaccination programs

Last year

Pharma

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

3 years ago

R&D

Marketing

A technicality could keep RSV shots from kids in need

3 years ago

R&D

As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine

3 years ago

R&D

Parents become drug developers to save their children’s lives

3 years ago

Pharma

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

3 years ago

R&D

Is Paxlovid, the Covid pill, reaching those who most need it? The government won’t say

4 years ago

Coronavirus

Scientists warn Americans are expecting too much from a coronavirus vaccine

5 years ago

Coronavirus

As Trump touts his ‘great’ Covid drugs, the pharma cash flows to Biden, not him

5 years ago

Pharma

Signs of an 'October Vaccine Surprise' alarm career scientists. HHS continues to claim Azar “will defer completely ...

5 years ago

Coronavirus

NIH ‘very concerned’ about serious side effect in AstraZeneca's PhIII Covid-19 trial

5 years ago

FDA+

Coronavirus

Covid-19 roundup: KHN: Fauci says Covid vaccine trials could end early, if...; HHS plans $250M campaign to 'defeat ...

5 years ago

Coronavirus

Warren and Klobuchar say they can lower drug prices without Congress’ help

6 years ago

People

Pharma

Voters say Congress needs to curb drug prices. So why do the odds look grim for major legislation this year?

6 years ago

Pharma

MDMA, now in Phase III, shows promise as a PTSD treatment

6 years ago

R&D

Experts question Amarin's early touting of Vascepa data ahead of detailed results

7 years ago

R&D

Trump administration sinks teeth into paring down drug prices, on 5 key points

7 years ago

Pharma

For shame: ‘Pharma Bro’ Shkreli is in prison, but Daraprim’s price is still high

8 years ago

Pharma

FDA launches criminal probe into unauthorized herpes vaccine R&D backed by Peter Thiel

8 years ago

People

University was tipped off to possible unauthorized trials of herpes vaccine

8 years ago

R&D

Cascade of costs could push CAR-T therapy to $1.5M per patient

8 years ago

Pharma

Right after Trump blamed high drug prices on campaign cash, drugmakers gave more

8 years ago

Pharma

about the author

author articles

New Alzheimer’s drug raises hopes — along with questions

CDC to reduce funding for states’ child vaccination programs

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

A technicality could keep RSV shots from kids in need

As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine

Parents become drug developers to save their children’s lives

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

Is Paxlovid, the Covid pill, reaching those who most need it? The government won’t say

Scientists warn Americans are expecting too much from a coronavirus vaccine

As Trump touts his ‘great’ Covid drugs, the pharma cash flows to Biden, not him

Signs of an 'October Vaccine Surprise' alarm career scientists. HHS continues to claim Azar “will defer completely ...

NIH ‘very concerned’ about serious side effect in AstraZeneca's PhIII Covid-19 trial

Covid-19 roundup: KHN: Fauci says Covid vaccine trials could end early, if...; HHS plans $250M campaign to 'defeat ...

Warren and Klobuchar say they can lower drug prices without Congress’ help

Voters say Congress needs to curb drug prices. So why do the odds look grim for major legislation this year?

MDMA, now in Phase III, shows promise as a PTSD treatment

Experts question Amarin's early touting of Vascepa data ahead of detailed results

Trump administration sinks teeth into paring down drug prices, on 5 key points

For shame: ‘Pharma Bro’ Shkreli is in prison, but Daraprim’s price is still high

FDA launches criminal probe into unauthorized herpes vaccine R&D backed by Peter Thiel

University was tipped off to possible unauthorized trials of herpes vaccine

Cascade of costs could push CAR-T therapy to $1.5M per patient

Right after Trump blamed high drug prices on campaign cash, drugmakers gave more